Communiqués

15/05 ScandiDos Unveils Delta4 SRS Pro at ESTRO 2026: Setting a New Standard for Stereotactic QA AQ
06/05 Anders Murman appointed Acting CEO of ScandiDos AQ
21/11/24 ScandiDos Expands with New Reference Center in Madrid, Spain AQ
18/04/24 Successful user meeting in Madrid highlights ScandiDos' innovative solutions AQ
20/12/23 ScandiDos receives orders worth €478 000 from China AQ
30/11/23 ScandiDos AB changes Certified Adviser and liquidity provider to Carnegie Investment Bank AB (publ) AQ
29/11/23 ScandiDos achieves EU Medical Device Regulation certification for the Delta4 Phantom+ product line AQ
28/06/23 ScandiDos receives orders worth €290 000 from China AQ
13/05/23 ScandiDos and IBA Dosimetry deepen strategic alliance! AQ
14/03/23 ScandiDos receives an order worth €263 000 from China AQ
23/02/23 ScandiDos sees growing demand for patient-specific QA in Chinese market AQ
01/11/22 ScandiDos receives an order of € 377 500 from Japan AQ
02/09/22 ScandiDos’ directed share issue completed AQ
30/08/22 ScandiDos has completed a directed share issue of 4,150,000 shares at a subscription price of SEK 3 per share AQ
25/02/22 ScandiDos launches Delta4 Insight which is immediately available to sell to customers in Europe and parts of Asia. AQ
16/02/22 ScandiDos : celebrates 20 years of success PU
16/02/22 ScandiDos Celebrates 20th Anniversary AQ
23/09/21 ScandiDos : Delårsrapport för perioden 1 maj 2021 – 31 jul 2021 PU
05/07/21 ScandiDos : selected as preferred QA partner by first Radixact® Synchrony®customer in France PU
08/06/21 ScandiDos : joins forces with Accuray to take motion synchronization QA to the next level PU
04/03/21 ScandiDos : Leading centers all over the world select Scandidos' Delta4 Phantom+ MR for their MR-linac programs AQ
Aucun résultat pour cette recherche
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT